Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

Author： Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.142, Iss.3, 2013-12, pp. : 559-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation

By Zhou Xianxiao   Li Bailiang   Zhang Yuannv   Gu Yunyan   Chen Beibei   Shi Tongwei   Ao Lu   Li Pengfei   Li Shan   Liu Chunyang   Guo Zheng  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 505-514

Springer Publishing Company

Access to resources Recommend Favorite

Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer

By Masuda Norikazu   Iwata Hiraji   Rai Yoshiaki   Anan Keisei   Takeuchi Toru   Kohno Norio   Takei Hiroyuki   Yanagita Yasuhiro   Noguchi Shinzaburo  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 443-451

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant!© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

By Paridaens Robert   Gelber Shari   Cole Bernard   Gelber Richard   Thürlimann Beat   Price Karen   Holmberg Stig   Crivellari Diana   Coates Alan   Goldhirsch Aron  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 303-310

Springer Publishing Company

Access to resources Recommend Favorite

Co-expression of estrogen receptor α and Apolipoprotein D in node positive operable breast cancer - possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

By Søiland Håvard   Skaland Ivar   Varhaug Jan Erik   Kørner Hartwig   Janssen Emiel   Gudlaugsson Einar   Baak Jan   Søreide Jon Arne  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 514-521

Informa Healthcare

Access to resources Recommend Favorite

Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer

By Ferretti Gianluigi  

Breast Cancer Research and Treatment, Vol. 90, Iss. 3, 2005-04 ,pp. : 319-319

Springer Publishing Company

Access to resources Recommend Favorite